(+/-)-METHADONE
- Product Name
- (+/-)-METHADONE
- CAS No.
- 76-99-3
- Chemical Name
- (+/-)-METHADONE
- Synonyms
- k174;Adanon;Amidone;Mecodin;Eptadone;Diaminon;Dolophin;Heptanon;Ketalgin;Methadon
- CBNumber
- CB9707025
- Molecular Formula
- C21H27NO
- Formula Weight
- 309.45
- MOL File
- 76-99-3.mol
(+/-)-METHADONE Property
- Melting point:
- 78°
- Boiling point:
- 449.71°C (rough estimate)
- Density
- 1.0350 (rough estimate)
- refractive index
- 1.5614 (estimate)
- Flash point:
- 9℃
- storage temp.
- −20°C
- pka
- pKa 8.25 (Uncertain)
- EPA Substance Registry System
- 3-Heptanone, 6-(dimethylamino)-4,4-diphenyl- (76-99-3)
Safety
- Hazard Codes
- F,T
- Risk Statements
- 11-23/24/25-39/23/24/25
- Safety Statements
- 7-16-36/37-45
- RIDADR
- UN1230 - class 3 - PG 2 - Methanol, solution
- WGK Germany
- 1
- Hazardous Substances Data
- 76-99-3(Hazardous Substances Data)
- Toxicity
- LD50 oral in rat: 86mg/kg
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H225Highly Flammable liquid and vapour
H370Causes damage to organs
- Precautionary statements
-
P210Keep away from heat/sparks/open flames/hot surfaces. — No smoking.
P260Do not breathe dust/fume/gas/mist/vapours/spray.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P311Call a POISON CENTER or doctor/physician.
N-Bromosuccinimide Price
- Product number
- M-019
- Product name
- (±)-Methadone solution
- Purity
- 100?μg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant?
- Packaging
- 1mL
- Price
- $32.8
- Updated
- 2022/05/15
- Product number
- M-007
- Product name
- (±)-Methadone solution
- Purity
- 1?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant?
- Packaging
- 1ML
- Price
- $23.8
- Updated
- 2022/05/15
- Product number
- M-2624
- Product name
- MethadoneHCl
- Packaging
- 25mg
- Price
- $1290
- Updated
- 2021/12/16
(+/-)-METHADONE Chemical Properties,Usage,Production
Originator
Dolophine ,Lilly,US,1947
Uses
Analgesic (narcotic).
Definition
ChEBI: A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Definition
methadone: A synthetic opioid,C21H27NO, used medically as an analgesicfor chronic pains and also as asubstitute for heroin in the treatmentof addiction. Methadone is itselfaddictive and considerablequantities of ‘street’ methadone areused in the UK.
Manufacturing Process
Diphenylacetonitrile is condensed with 2-chloro-1-dimethylaminopropane to give 4-(dimethylamino)-2,2-diphenyl valeronitrile. It is then reacted with ethyl magnesium bromide and then hydrolyzed using HCl to give methadone hydrochloride.
brand name
Dolophine Hydrochloride (Roxane); Dolophine Hydrochloride (Xanodyne); Methadose (Mallinckrodt); Westadone (Sandoz).
Therapeutic Function
Narcotic analgesic
Biological Functions
Methadone (Dolophine) has an analgesic profile and
potency similar to that of morphine but a longer duration
of action and better oral bioavailability.The kinetic
properties of methadone and its derivative, LAAM,
have been shown to be useful in the treatment of opioid
addiction.
Methadone is a useful analgesic drug for the treatment
of moderate to severe pain. Unlike morphine, it is
generally not used epidurally because of its long duration
of action. It is also rarely or never used in PCA systems
or in pregnant women during labor. The side effects
and signs of overdose following methadone
administration are similar to those observed with morphine.
Overdose is treated with naloxone. Clearance of
methadone is via the urine and bile as the cyclic Ndemethylated
drug. The ability to N-demethylate the
drug decreases in elderly patients, prolonging the action of methadone. In such patients, dosing intervals should
be longer than in younger patients. In addition, the pH
of the urine has a major effect on clearance of the drug.
Alkalinization of the urine or renal insufficiency decreases
excretion of the drug.
Drug interactions and precautions for the use of
methadone are similar to those of morphine. In addition,
rifampicin and hydantoins markedly increase the
metabolism of methadone and can precipitate withdrawal
from methadone. Conversely, the tricyclic antidepressants
and certain benzodiazepines can inhibit
metabolism of methadone, thereby increasing accumulation
of the drug, prolonging its half-life, and intensifying
its side effects. Continuous dosing with methadone
may lead to drug accumulation and to an increased incidence
of side effects; methadone is generally not used
for PCA. In pregnant heroin-addicted women, substitution
of methadone for heroin has been shown to be associated
with fewer low-birth-weight newborns and
fewer learning and cognition problems later in the life
of the child.
General Description
Methadone (Dolophine) is a synthetic opioid approved for analgesic therapy and for the maintenance and treatment of opioid addiction. Methadone is marketed as the racemate, although the opioid activity resides in the R-enantiomer (7–50 times more potent than the S-enantiomer). Methadone may only be dispensed for the treatment of opioid addiction by a program certified by the Federal Substance Abuse and Mental Health Services Administration.
Methadone is a μ-receptor agonist with complex and highly variable pharmacokinetic parameters. The major metabolic pathway of methadone metabolism is via Ndemethylation to an unstable product that spontaneously cyclizes to form the inactive 2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine (EDDP).
Pharmacology
Methadone is a diphenylpropylamine. It has very good oral bioavailability (~85%) with an oral to parenteral ratio of 1:2. Its plasma half-life can be highly variable (3–50h, average 24h) but its duration of action is relatively short. With repeated dosing, problems with accumulation can occur because of this discrepancy between half-life and analgesic effect. Careful monitoring is therefore required when converting patients to long-term methadone. A lso, there is incomplete cross-tolerance with morphine. The racemic mixture in common use has agonist actions at the MOP receptor (mainly the laevo isomer) as well as antagonist activity at the NMDA receptor dextro isomer). Given the importance of this receptor in central sensitisation in a variety of pain states, there may be cases where methadone offers particular advantages over and above other opioids (e.g. neuropathic pain). Plasma concentrations of methadone can be reduced by carbamazepine, and its metabolism is accelerated by phenytoin.
Safety Profile
Poison by ingestion, intraperitoneal, intravenous, subcutaneous, and intraduodenal routes. Human systemic effects: coma, nausea or vomiting, respiratory changes, respiratory depression, somnolence. An experimental teratogen. Experimental reproductive effects. Caution: Abuse leads to habituation or addiction. When heated to decomposition it emits toxic fumes of NOx. See also METHADONE HYDROCHLORIDE.